Funded Tech Companies

Imbria Pharmaceuticals

Based in Boston, Imbria Pharmaceuticals has funding from AXA IM Alts, Catalio Capital Management and RA Capital Management.

Company Overview

Contact Information

Company Background Information

Overview

At Imbria, we are using our deep understanding of energy metabolism to develop novel therapies designed to substantially improve the lives of patients with life-altering cardiometabolic disorders. Our clinical stage pipeline is focused on restoring or improving the cell's ability to produce energy in cardiovascular diseases where energetic impairment is a fundamental contributor.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/19/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alvin Shih

        

Company Investors

• AXA IM Alts
• Catalio Capital Management
• RA Capital Management
• Deep Track Capital
• SV Health Investors

Browse more funded tech companies:

Imbellus | Imbue

Share this article

About Our Venture Capital Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary